LAB — Labiana Health SA Balance Sheet
0.000.00%
- €28.62m
- €30.11m
- €66.26m
- 86
- 58
- 89
- 95
Annual balance sheet for Labiana Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2.41 | 3.29 | 2.54 | 2.97 | 6.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12.5 | 11 | 11.9 | 13.5 | 10.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 29.3 | 29.4 | 28.8 | 29 | 28.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 20.3 | 20.4 | 20.6 | 19.8 | 12.7 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 66 | 68.4 | 60.8 | 59.1 | 52 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.8 | 30.5 | 35.1 | 24.7 | 22.2 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 51.7 | 56.3 | 53 | 54.8 | 48.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 14.3 | 12.1 | 7.74 | 4.31 | 3.52 |
| Total Liabilities & Shareholders' Equity | 66 | 68.4 | 60.8 | 59.1 | 52 |
| Total Common Shares Outstanding |